Bausch Health Companies Inc. (BHC)

23.13
0.08 0.35
NYSE
Prev Close 23.05
Open 23.08
Day Low/High 22.68 / 23.30
52 Wk Low/High 14.44 / 28.45
Volume 4.22M
Exchange NYSE
Shares Outstanding 351.01B
Market Cap 8.09B
Div & Yield N.A. (N.A)

Latest News

These 3 Biotech Stocks Are Moving Closer to Profitability

These 3 Biotech Stocks Are Moving Closer to Profitability

Here are updates on small biotech/biopharma names I have profiled before.

Bausch Health Companies Inc. Will Release First-Quarter 2019 Financial Results On May 6

Bausch Health Companies Inc. Will Release First-Quarter 2019 Financial Results On May 6

LAVAL, Quebec, April 8, 2019 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") will release its first-quarter 2019 financial results on Monday, May 6, 2019.

My Post-Earnings Assessment of 2 Biotech Stocks

My Post-Earnings Assessment of 2 Biotech Stocks

Let's look at a couple of companies we have covered on these pages before.

Ortho Dermatologics Launches 2019 Aspire Higher Scholarship Program For Students With Dermatologic Conditions

Ortho Dermatologics Launches 2019 Aspire Higher Scholarship Program For Students With Dermatologic Conditions

  Students Can Apply for the Scholarship Through April 26, 2019 LAVAL, Quebec, March 11, 2019 /PRNewswire/ -- Ortho Dermatologics, one of the largest prescription dermatology health care businesses, and its parent company, Bausch Health Companies Inc.

Bausch Health Announces Closing Of Senior Secured Notes And Add-On Unsecured Notes, As Well As Redemption Of Existing Senior Notes

Bausch Health Announces Closing Of Senior Secured Notes And Add-On Unsecured Notes, As Well As Redemption Of Existing Senior Notes

LAVAL, Quebec, March 8, 2019 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") announced today that it has closed its previously announced offering of $500,000,000 aggregate principal amount of 5.

Bausch Health Announces Early Tender Results And Early Settlement Date For Cash Tender Offers And Consent Solicitation For Senior Notes

Bausch Health Announces Early Tender Results And Early Settlement Date For Cash Tender Offers And Consent Solicitation For Senior Notes

LAVAL, Quebec, March 8, 2019 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health," the "Company" or the "Offeror") announced today the results to date of its pending cash tender offers (collectively, the "Tender Offers," and each...

Bausch Health Completes Acquisition Of Certain Assets Of Synergy Pharmaceuticals Inc.

Bausch Health Completes Acquisition Of Certain Assets Of Synergy Pharmaceuticals Inc.

LAVAL, Quebec, March 6, 2019 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") announced today that the Company has completed the acquisition of certain assets of Synergy Pharmaceuticals Inc.

Rules of Biotech Investing Change, and So Must Biotech Investors

Rules of Biotech Investing Change, and So Must Biotech Investors

One big change over the last few years has been the struggle of small concerns to penetrate mass markets even with approved and superior drugs.

Ortho Dermatologics To Present New Analyses At The American Academy Of Dermatology Annual Meeting

Ortho Dermatologics To Present New Analyses At The American Academy Of Dermatology Annual Meeting

  10 Poster Presentations Include New Analyses of Phase 3 Data on Investigational Drug DUOBRII ™1 a nd SILIQ ™  LAVAL, Quebec, Feb.

Bausch Health To Acquire Certain Assets Of Synergy Pharmaceuticals Inc.

Bausch Health To Acquire Certain Assets Of Synergy Pharmaceuticals Inc.

Bausch Health and Synergy to Seek Bankruptcy Court Approval of Sale on March 1, 2019 LAVAL, Quebec, Feb.

Bausch Health Announces Upsize Of Cash Tender Offers And Consent Solicitation To $1,500,000,000 Aggregate Purchase Price

Bausch Health Announces Upsize Of Cash Tender Offers And Consent Solicitation To $1,500,000,000 Aggregate Purchase Price

LAVAL, Quebec, Feb. 22, 2019 /PRNewswire/ -- Bausch Health Companies Inc.

Bausch Health Announces Pricing Of Private Offering Of Senior Secured Notes And Add-On Unsecured Notes

Bausch Health Announces Pricing Of Private Offering Of Senior Secured Notes And Add-On Unsecured Notes

LAVAL, Quebec, Feb. 22, 2019 /PRNewswire/ -- Bausch Health Companies Inc.

Bausch Health Announces Launch Of Private Offering Of Senior Secured Notes And Add-On Unsecured Notes

Bausch Health Announces Launch Of Private Offering Of Senior Secured Notes And Add-On Unsecured Notes

LAVAL, Quebec, Feb. 22, 2019 /PRNewswire/ -- Bausch Health Companies Inc.

Bausch Health Commences Cash Tender Offers And Consent Solicitation For Up To $1,250,000,000 Aggregate Purchase Price

Bausch Health Commences Cash Tender Offers And Consent Solicitation For Up To $1,250,000,000 Aggregate Purchase Price

LAVAL, Quebec, Feb. 22, 2019 /PRNewswire/ -- Bausch Health Companies Inc.

Bausch Health Swings to Loss but Revenue Tops Analysts' Expectations

Bausch Health Swings to Loss but Revenue Tops Analysts' Expectations

Bausch Health swings to a loss in the fourth quarter but issues positive revenue guidance for fiscal 2019.

Dow Rises as Fed Says Growth Risks Cause Pause in Rate Hikes

Dow Rises as Fed Says Growth Risks Cause Pause in Rate Hikes

Stocks are higher as Wall Street digests the Federal reserve minutes which explained why the central bank paused its plan to raise rates.

3 Small Biotechs to Watch as Earnings Season Winds Down

3 Small Biotechs to Watch as Earnings Season Winds Down

One already is up nicely on its results, while the other two should issue reports of interest in the next few days.

Bausch Health Companies Inc. Announces Fourth-Quarter And Full-Year 2018 Results And Provides 2019 Guidance

Bausch Health Companies Inc. Announces Fourth-Quarter And Full-Year 2018 Results And Provides 2019 Guidance

LAVAL, Quebec, Feb. 20, 2019 /PRNewswire/ -- Fourth-Quarter 2018 Financial Results Revenues of $2.

Bausch Health Is Likely to Dip Before Moving Higher Longer-Term

Bausch Health Is Likely to Dip Before Moving Higher Longer-Term

Traders look like they have taken a neutral to bearish stance ahead of earnings.

Bausch Health Acquires Eton Pharmaceuticals' EM-100 Investigational Eye Drop For The Treatment Of Itchy Eyes Associated With Allergies

Bausch Health Acquires Eton Pharmaceuticals' EM-100 Investigational Eye Drop For The Treatment Of Itchy Eyes Associated With Allergies

If Approved, EM-100 Will Be the First OTC Preservative-Free Formulation of Its Kind EM-100 Has Been Submitted to the FDA for Review LAVAL, Quebec and DEER PARK, Ill.

The Week Ahead: Housing, Fed Minutes and 13 Tell-Tale Earnings Reports to Watch

The Week Ahead: Housing, Fed Minutes and 13 Tell-Tale Earnings Reports to Watch

A shortened week still brings key economic numbers and earnings results.

Don't Underestimate a Trade Deal: Cramer's 'Mad Money' Recap (Friday 02/15/19)

Don't Underestimate a Trade Deal: Cramer's 'Mad Money' Recap (Friday 02/15/19)

Don't underestimate how positive an actual trade deal with China would be for American companies, Jim Cramer argues.

Bausch Health Provides Update For DUOBRII Filing

Bausch Health Provides Update For DUOBRII Filing

LAVAL, Quebec, Feb. 15, 2019 /PRNewswire/ -- Bausch Health Companies Inc.

Bausch Lomb Launches SightMatters.com To Help People Living With Age-Related Macular Degeneration Take Control Of Their Condition

Bausch Lomb Launches SightMatters.com To Help People Living With Age-Related Macular Degeneration Take Control Of Their Condition

  New Website offers Comprehensive, Educational Resources to Navigate Life with AMD BRIDGEWATER, N.

Bausch Health Companies Announces Participation In Upcoming Investor Conferences

Bausch Health Companies Announces Participation In Upcoming Investor Conferences

LAVAL, Quebec, Feb. 1, 2019 /PRNewswire/ -- Bausch Health Companies Inc.

Bausch Health Reduces Debt By Additional $100 Million

Bausch Health Reduces Debt By Additional $100 Million

LAVAL, Quebec, Jan. 29, 2019 /PRNewswire/ -- Bausch Health Companies Inc.

TheStreet Quant Rating: D+ (Sell)